Security key
13463J101
Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP)
CUSIP: 13463J101
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 51,921,834
- Total 13F shares
- 38,247,378
- Share change
- +8,053,354
- Total reported value
- $234,599,194
- Price per share
- $6.13
- Number of holders
- 39
- Value change
- +$51,453,984
- Number of buys
- 23
- Number of sells
- 10
Report period
Q4 2025
Institutions
39
Top holders
10
CAMP full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Camp4 Therapeutics Corp SEC filings
Camp4 Therapeutics Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 13463J101
Recent filing periods:
Top shareholders of CAMP - Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 5AM Ventures VI, L.P. |
13D/G
|
Andrew J. Schwab |
12%
|
5,869,091
|
$8,392,800 | $0 | 09 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
12%
|
6,307,636
|
$37,908,892 | $0 | 31 Dec 2025 | |
| Coastlands Capital LP |
13D/G
|
— |
10%
|
4,886,722
|
$21,452,710 | $0 | 10 Sep 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
9.5%
|
4,918,243
|
$28,968,451 | +$10,440,496 | 31 Dec 2025 | |
| Polaris Management Co. VII, L.L.C. |
13D/G
3/4/5
|
Amir Nashat · 10%+ Owner |
8.4%
|
3,932,251
|
$5,623,119 | $0 | 09 Sep 2025 | |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
7.4%
|
3,856,991
|
$23,373,365 | +$1,788,900 | 31 Dec 2025 | |
| Northpond Ventures II, LP |
13D/G
|
Michael P. Rubin |
4.8%
|
2,238,244
|
$6,714,732 | $0 | 30 Sep 2025 | |
| AH Bio Fund I, L.P. |
13D/G
|
Marc L. Andreessen |
4.5%
|
2,125,339
|
$6,376,017 | $0 | 30 Sep 2025 | |
| HARBOURVEST PARTNERS LLC |
13F
13D/G
|
Company · HarbourVest Partners L.P. |
2.7%
from 13D/G
|
1,271,948
|
$3,815,844 | — | 30 Sep 2025 | |
| 5AM Partners VI, LLC |
3/4/5
|
10%+ Owner |
11%
|
5,869,091
|
$8,686,917 | +$4,499,999 | 11 Sep 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
11%
|
5,869,091
|
$17,607,273 | — | 30 Sep 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
7.6%
|
3,921,568
|
$11,764,704 | — | 30 Sep 2025 | |
| Enavate Sciences GP, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
7.3%
|
3,785,802
|
$11,357,406 | — | 30 Sep 2025 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
4.1%
|
2,125,339
|
$6,376,017 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.8%
|
1,960,784
|
$5,882,352 | — | 30 Sep 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
653,594
|
$1,960,782 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.6%
|
313,506
|
$940,518 | — | 30 Sep 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.39%
|
200,000
|
$600,000 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
97,371
|
$292,113 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
95,071
|
$285,213 | — | 30 Sep 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.16%
|
82,790
|
$248,370 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
60,371
|
$181,113 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
26,000
|
$78,000 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
25,000
|
$75,000 | — | 30 Sep 2025 | |
| Mariner, LLC |
13F
|
Company |
0.03%
|
17,298
|
$51,894 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
14,615
|
$43,845 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.02%
|
11,437
|
$34,311 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,043
|
$21,129 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,649
|
$16,947 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
953
|
$3,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
283
|
$849 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
78
|
$234 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
70
|
$210 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
15
|
$45 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3
|
$9 | — | 30 Sep 2025 | |
| Andrew J. Schwab |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
5,878,091
mixed-class rows
|
$8,686,917 | — | 11 Sep 2025 | |
| Amir Nashat |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
206,661
mixed-class rows
|
$302,421 | +$1,999,999 | 11 Sep 2025 | |
| Northpond Ventures II GP, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,238,244
|
— | — | 15 Oct 2024 | |
| AH Equity Partners Bio I, L.L.C. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,125,339
|
— | — | 15 Oct 2024 | |
| Polaris Partners GP X, L.L.C. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
909,090
|
— | — | 15 Oct 2024 | |
| Richard A. Young |
3/4/5
|
Director |
—
mixed-class rows
|
179,010
mixed-class rows
|
$280,516 | +$24,999 | 11 Sep 2025 | |
| Steven H. Holtzman |
3/4/5
|
Director |
—
mixed-class rows
|
117,946
mixed-class rows
|
— | — | 25 Jun 2025 | |
| David Bumcrot |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
106,741
mixed-class rows
|
— | — | 01 Apr 2025 | |
| Michael J. Higgins |
3/4/5
|
Director |
—
mixed-class rows
|
37,739
mixed-class rows
|
— | — | 25 Jun 2025 | |
| Paula Ragan |
3/4/5
|
Director |
—
mixed-class rows
|
29,232
mixed-class rows
|
— | — | 25 Jun 2025 | |
| Ravi I. Thadhani |
3/4/5
|
Director |
—
mixed-class rows
|
26,014
mixed-class rows
|
— | — | 25 Jun 2025 | |
| Douglas E. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
20,288
mixed-class rows
|
— | — | 17 Mar 2025 | |
| Murray Stewart |
3/4/5
|
Director |
—
class O/S missing
|
17,787
|
— | — | 17 Mar 2025 | |
| James P. Boylan |
3/4/5
|
Director |
—
class O/S missing
|
9,000
|
— | — | 25 Jun 2025 |
Institutional Holders of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) as of Q4 2025
As of 31 Dec 2025,
Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,247,378 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, 5AM Venture Management, LLC, FMR LLC, Vivo Capital, LLC, ENAVATE SCIENCES GP, LLC, Balyasny Asset Management L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., a16z Capital Management, L.L.C., Trails Edge Capital Partners, LP, and VANGUARD GROUP INC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
28
Q4 2025 holders
39
Holder diff
11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.